-3 PUFAs alleviate high-fat diet-induced circadian intestinal microbes dysbiosis (in Eng)
declares having received consulting honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer, and research grants from British Heart Foundation, MRC (UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate and Roche
Many patients report increased energy within a day or two, with weight-loss benefits developing over several weeks of consistent use
Butaphosphan acts as an anabolic agent and is included in the stimulation process of the transformation of food into living tissue